Literature DB >> 21424908

Medical treatment of colonic diverticular disease: are we sure the aim is right?

Gabrio Bassotti, Vincenzo Villanacci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21424908     DOI： 10.1007/s11739-011-0562-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  17 in total

1.  Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.

Authors:  Luigi Gatta; Francesco Di Mario; Margherita Curlo; Dino Vaira; Alberto Pilotto; Paolo Lucarini; Maurizio Lera; Kajo Enkleda; Angelo Franzé; Carmelo Scarpignato
Journal:  Intern Emerg Med       Date:  2011-01-29       Impact factor: 3.397

Review 2.  Diverticular disease of the colon in Europe: epidemiology, impact on citizen health and prevention.

Authors:  M Delvaux
Journal:  Aliment Pharmacol Ther       Date:  2003-11       Impact factor: 8.171

3.  The overlap of inflammatory bowel disease and diverticular disease.

Authors:  Mark A Peppercorn
Journal:  J Clin Gastroenterol       Date:  2004 May-Jun       Impact factor: 3.062

Review 4.  Efficacy of 5-ASA in the treatment of colonic diverticular disease.

Authors:  Luigi Gatta; Nimish Vakil; Dino Vaira; Alberto Pilotto; Margherita Curlo; Giuseppe Comparato; Gioacchino Leandro; Umberto Ferro; Maurizio Lera; Sergio Milletti; Francesco Di Mario
Journal:  J Clin Gastroenterol       Date:  2010-02       Impact factor: 3.062

Review 5.  Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome.

Authors:  Giovanni Barbara; Vincenzo Stanghellini; Cesare Cremon; Roberto De Giorgio; Lucia Fronzoni; Mauro Serra; Roberto Corinaldesi
Journal:  Dig Dis       Date:  2010-03-04       Impact factor: 2.404

6.  Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease.

Authors:  G Bassotti; E Battaglia; G Bellone; L Dughera; S Fisogni; C Zambelli; A Morelli; P Mioli; G Emanuelli; V Villanacci
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

Review 7.  Features and management of colonic diverticular disease.

Authors:  Jason Hemming; Martin Floch
Journal:  Curr Gastroenterol Rep       Date:  2010-10

8.  Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study.

Authors:  David J Humes; Kate M Fleming; Robin C Spiller; Joe West
Journal:  Gut       Date:  2010-10-12       Impact factor: 23.059

Review 9.  Treatment options for uncomplicated diverticular disease of the colon.

Authors:  Alba Rocco; Debora Compare; Flora Caruso; Gerardo Nardone
Journal:  J Clin Gastroenterol       Date:  2009-10       Impact factor: 3.062

10.  Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study.

Authors:  R Corinaldesi; V Stanghellini; C Cremon; L Gargano; R F Cogliandro; R De Giorgio; G Bartesaghi; B Canovi; G Barbara
Journal:  Aliment Pharmacol Ther       Date:  2009-05-12       Impact factor: 8.171
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.